Omnicell (OMCL) “announced new products designed to streamline workflows and enhance inventory visibility and management in perioperative and clinic settings. These products, which leverage RFID tracking and intelligent software workflows, expand Omnicell’s connected platform that is intended to automate medication management processes and deliver intelligent insights to drive clinical and operational outcomes across all settings of care.”
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OMCL:
- Omnicell opens new Innovation Lab in Austin, Texas
- Omnicell upgraded to Overweight from Equal Weight at Wells Fargo
- Positive Outlook for Omnicell: Strong Demand and Market Stability Drive Buy Rating
- Omnicell price target lowered to $53 from $64 at Craig-Hallum
- Omnicell price target lowered to $30 from $37 at BofA
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue